Liothyronine Sodium

Product NDC
53217-361
11-digit product format
532170361
Labeler code
53217
Product ID
53217-361_4851a1c6-ffc2-45fe-a849-4e8c4c5eca3c
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Liothyronine Sodium
Dosage form
TABLET
Route
ORAL
Labeler
Aidarex Pharmaceuticals LLC
Application
ANDA200295
Marketing category
ANDA
Marketing start
2018-01-11
Marketing end
0000-00-00
Substance
LIOTHYRONINE SODIUM
Active strength
5 ug/1
Pharmacologic classes
l-Triiodothyronine [EPC],Triiodothyronine [CS]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b42496cd-a994-8ba1-597f-e507aa62246eProduct name520250116

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
53217-361-302020-01-31C16284748780-19d75b9d1-12f3-f424-e053-dadaa90a57ceLIOTHYRONINE SODIUM TABLETS, USP

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53217-361-30Liothyronine Sodium30 in 1 BOTTLETABLET301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
53217-361LIOTHYRONINE SODIUM TABLET [AIDAREX PHARMACEUTICALS LLC]1Legacy NDC, 1 package rows20180821_818ae20e-9909-41ec-a0a9-4b6e9e86e794.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
903456liothyronine sodium 5 MCG Oral TabletPSN818ae20e-9909-41ec-a0a9-4b6e9e86e7941
903456liothyronine sodium 0.005 MG Oral TabletSCD818ae20e-9909-41ec-a0a9-4b6e9e86e7941
903456liothyronine sodium 5 MCG Oral TabletSY818ae20e-9909-41ec-a0a9-4b6e9e86e7941

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
53217-361-305321703613030 in 1 BOTTLEHistorical